Loading…
BGM Group Ltd. is projected to decline to $0.3206 by 2027, a -4% move from its current price of $0.335. BGM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3092 | $0.3351 | $0.3633 | +0.04% |
| Jul 14 | $0.2991 | $0.3353 | $0.3758 | +0.08% |
| Jul 15 | $0.2917 | $0.3354 | $0.3857 | +0.12% |
| Jul 16 | $0.2855 | $0.3355 | $0.3943 | +0.16% |
| Jul 17 | $0.2803 | $0.3357 | $0.4021 | +0.20% |
| Jul 18 | $0.2756 | $0.3358 | $0.4092 | +0.24% |
| Jul 19 | $0.2714 | $0.336 | $0.4159 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2714 | $0.336 | $0.4159 | +0.29% |
| Week 2 | $0.2491 | $0.3369 | $0.4556 | +0.57% |
| Week 3 | $0.2334 | $0.3379 | $0.489 | +0.86% |
| Week 4 | $0.2211 | $0.3388 | $0.5193 | +1.15% |
| Week 5 | $0.2108 | $0.3398 | $0.5477 | +1.43% |
| Week 6 | $0.202 | $0.3408 | $0.5749 | +1.72% |
| Week 7 | $0.1943 | $0.3417 | $0.6012 | +2.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient.
The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes.
Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform.
BGM Group Ltd. (BGM) is a healthcare-focused company with a current price of $0.3332 and a market cap of $133.49M, ranking 4081 by market size. The stock trades in the healthcare category, with a diversified product slate spanning oxytetracycline, licorice-derived ingredients, traditional Chinese medicine derivatives, heparin products, sausage casings, and agricultural inputs, plus AI-enabled platform initiatives.
The 30-day technical picture shows a neutral setup, with a 30-day price range of $0.1897 to $0.5852 and key levels near $0.29 support and $0.459 resistance. Traders should note RSI(14) at 50, SMA50 at $0.3263, and SMA200 at $3.70, alongside an implied annualized volatility of 200%.
Forecasts by year present a mixed-to-challenging near term followed by later-year strength. The 2026 avg is $0.3332 with ROI 0 and neutral sentiment, while 2032-2050 show bullish turns with higher averages and positive ROIs, culminating in a strong 2050 outturn of $0.9406 avg and 182.3 ROI.
A major floor 42.6% below — a decisive break under it would weaken the trend.
The nearest floor, 13.4% below — buyers have tended to step in here.
The nearest ceiling, 37.0% above — a clean break opens room to run.
A major ceiling 231.3% above — clearing it would confirm fresh momentum.
Key BGM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BGM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3404 | Sell | $0.3378 | Sell |
| MA 10 | $0.3456 | Sell | $0.3426 | Sell |
| MA 20 | $0.3581 | Sell | $0.3454 | Sell |
| MA 50 | $0.3262 | Buy | $0.4242 | Sell |
| MA 100 | $0.502 | Sell | $1.11 | Sell |
| MA 200 | $3.56 | Sell | $2.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.31 | Neutral |
| Stoch RSI (14) | 36.54 | Neutral |
| CCI (20) | -52.53 | Neutral |
| Williams %R (14) | -66.67 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -2.05 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 33.33 | Neutral |
| TRIX (15) | 0.18 | Buy |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 44.06 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.33 | Buy |
| ADX (14) | 9.25 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is Neutral overall. RSI(14) sits at 50, signaling neutral momentum around the midpoint. The stock trades near a 50-day moving average at $0.3263 and a 200-day moving average near $3.70, suggesting limited near-term directional bias.
Near-term support sits at $0.29 with resistance at $0.459. The 30-day price range spans from a low of $0.1897 to a high of $0.5852, indicating notable volatility within a relatively tight price corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.261 | $0.335 | $0.4337 | 0% | Neutral | |
| $0.2326 | $0.3206 | $0.4778 | -4% | Neutral | |
| $0.1725 | $0.2526 | $0.4013 | -25% | Bearish | |
| $0.1725 | $0.2661 | $0.4437 | -21% | Bearish | |
| $0.1819 | $0.2942 | $0.5107 | -12% | Neutral | |
| $0.1857 | $0.314 | $0.5642 | -6% | Neutral | |
| $0.228 | $0.4021 | $0.7448 | +20% | Bullish | |
| $0.2154 | $0.3956 | $0.7532 | +18% | Neutral | |
| $0.1688 | $0.3225 | $0.6296 | -4% | Neutral | |
| $0.1666 | $0.3309 | $0.6609 | -1% | Neutral | |
| $0.2045 | $0.4544 | $0.9976 | +36% | Bullish | |
| $0.4245 | $0.9433 | $2.17 | +182% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.261 | $0.335 | $0.3986 | +0.00% |
| August 2026 | $0.2728 | $0.3305 | $0.4173 | -1.33% |
| September 2026 | $0.2829 | $0.3477 | $0.448 | +5.18% |
| October 2026 | $0.2719 | $0.3382 | $0.4435 | -2.71% |
| November 2026 | $0.2539 | $0.3191 | $0.4244 | -5.66% |
| December 2026 | $0.2535 | $0.3218 | $0.4337 | +0.85% |
Click any year to see its month-by-month BGM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BGM Group Ltd.'s 2026 outlook centres on $0.335, within a $0.261 to $0.4337 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, BGM could reach as high as $0.4778, with a base case around $0.3206 and support toward $0.2326 — roughly -4% from $0.335. Price action looks broadly range-bound.
Expect BGM to range from $0.1725 to $0.4013 through 2028. The $0.2526 average target implies a -25% move from current prices. That is -21% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The BGM price prediction for 2029 points to an average of $0.2661 (low $0.1725, high $0.4437) — a potential decline of -21% on today's $0.335. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, BGM is projected to trade between $0.1819 and $0.5107, averaging $0.2942 — a potential decline of -12% from today's $0.335. That is up +11% on the projected 2029 average. A consolidation phase looks the most probable path here.
BGM Group Ltd.'s 2031 outlook centres on $0.314, within a $0.1857 to $0.5642 range. That is up +7% on the projected 2030 average. That marks a -6% change versus current levels. Price action looks broadly range-bound.
By 2032, BGM could reach as high as $0.7448, with a base case around $0.4021 and support toward $0.228 — roughly +20% from $0.335. Buyers look set to stay in control over this stretch.
Expect BGM to range from $0.2154 to $0.7532 through 2033. The $0.3956 average target implies a +18% move from current prices. That is -2% versus the projected 2032 average. Price action looks broadly range-bound.
The BGM price prediction for 2034 points to an average of $0.3225 (low $0.1688, high $0.6296) — a potential decline of -4% on today's $0.335. A consolidation phase looks the most probable path here.
In 2035, BGM is projected to trade between $0.1666 and $0.6609, averaging $0.3309 — a potential decline of -1% from today's $0.335. That is up +3% on the projected 2034 average. Price action looks broadly range-bound.
BGM Group Ltd.'s 2040 outlook centres on $0.4544, within a $0.2045 to $0.9976 range. That is up +37% on the projected 2035 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, BGM could reach as high as $2.17, with a base case around $0.9433 and support toward $0.4245 — roughly +182% from $0.335. Momentum favours further upside here.
Investing $1,000 in BGM today (≈ 2,985.074627 BGM) could be worth
$2,815.93
+$1,815.93 (+182%) by 2050 · US Dollar
Based on the average projected BGM price of $0.94 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BGMwould be worth at today's price.
$1,000 invested in BGM on Jul 10, 2025 (≈ 103.51967 BGM) would be worth
$34.68
-$965.32 (-96.5%) today · 0.03× · US Dollar
Based on a BGM entry price of $9.66 vs. today's $0.335.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.324 | $1,033.95 | +3.4% |
| 1 month ago | $0.425 | $788.24 | -21.2% |
| 3 months ago | $0.342 | $979.53 | -2.0% |
| 6 months ago | $3.84 | $87.24 | -91.3% |
| 1 year ago | $9.66 | $34.68 | -96.5% |
| All time (5.0y) ago | $21.75 | $15.4 | -98.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BGM forecast.
Our base-case forecast reaches $0.67 around 2050.
Implied market cap at $0.67: $255.02M
The multi-year forecast shows an uneven path with a mixed start and stronger later upside. The 2026 average price is $0.3332 with ROI 0 and neutral sentiment, followed by 2027 average $0.3172 with ROI -4.8 and neutral sentiment, and 2028 average $0.2516 with ROI -24.5 and bearish sentiment.
Continuing, 2029 average $0.2662 with ROI -20.1 and bearish sentiment; 2030 average $0.2913 with ROI -12.6 and neutral sentiment; 2031 average $0.3122 with ROI -6.3 and neutral sentiment. A bullish inflection appears in 2032 with average $0.4023 and ROI 20.7, then 2033 average $0.3924 with ROI 17.8 and neutral sentiment, 2034 average $0.3189 with ROI -4.3 and neutral sentiment, and 2035 average $0.331 with ROI -0.7 and neutral sentiment.
The horizon brightens further into 2040 (avg $0.452, ROI 35.6, bullish) and 2050 (avg $0.9406, ROI 182.3, bullish), suggesting meaningful upside potential later in the forecast period. These figures indicate substantial long-run volatility with meaningful upside risk and the possibility of outsized gains by the end of the period, but they come with corresponding downside risks in earlier years.
Tap a question to reveal the answer.
2030 avg $0.2913, min $0.18, max $0.5058, ROI -12.6, sentiment Neutral.
The forecast shows mixed signals: neutral for several years (e.g., 2026 with avg $0.3332 and ROI 0; 2030 with avg $0.2913 and ROI -12.6; 2031 with avg $0.3122 and ROI -6.3) and bearish in 2028-2029, with bullish upside in 2032, 2040, and 2050.
Yes. The 2050 maximum forecast is $2.16, indicating a potential above-$2.00 level in the long run.
Current price is $0.3332 and market cap is $133.49M.
RSI(14) is 50; SMA(50) is $0.3263; SMA(200) is $3.70. The 30-day range is $0.1897 to $0.5852, with support at $0.29 and resistance at $0.459.
BGM Group Ltd. Community Discussion
0Share your BGM Group Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.